Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment

BACKGROUND: Intracranial metastasis that failed standard systematic treatment is common in advanced non-small cell lung cancer (NSCLC), contributing significantly to morbidity and mortality. The aim of this study was to evaluate the efficacy and safety of anlotinib combined with whole-brain radiothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Cheng, Yu, Shaorong, Qian, Pudong, Song, Xue, Wen, Jing, Jiang, Ming, Zhu, Jun, Xu, Jianhua, Zhao, Lijun, Guo, Zhen, Wu, Jianfeng, He, Xia, Zhu, Xiangzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523148/
https://www.ncbi.nlm.nih.gov/pubmed/37771446
http://dx.doi.org/10.3389/fonc.2023.1169333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523148/
https://www.ncbi.nlm.nih.gov/pubmed/37771446
http://dx.doi.org/10.3389/fonc.2023.1169333

Ejemplares similares